Cas:157327-53-2 4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridine hydrochloride manufacturer & supplier

Chemical Name:4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridine hydrochloride

CAS.NO:157327-53-2

Synonyms:4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridine hydrochloride

Molecular Formula:C₆H₉ClN₂O

Molecular Weight:160.60146

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridine hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridine hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridine hydrochloride Use and application,4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridine hydrochloride technical grade,usp/ep/jp grade.

Related News: Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia. 4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridine hydrochloride manufacturer If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. 4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridine hydrochloride supplier There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space. 4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridine hydrochloride vendor If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. 4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridine hydrochloride factory Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.